Renovaro Biosciences Inc. (NASDAQ: RENB)
$0.7526
-0.0814 ( -9.76% ) 497.6K
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.
Market Data
Open
$0.7526
Previous close
$0.8340
Volume
497.6K
Market cap
$128.82M
Day range
$0.7520 - $0.8720
52 week range
$0.3950 - $5.2500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 1 | Oct 31, 2024 |
| 8-k/a | 8K-related | 13 | Oct 29, 2024 |
| 4 | Insider transactions | 1 | Oct 29, 2024 |
| 3 | Insider transactions | 1 | Oct 29, 2024 |
| 10-k/a | Quarterly Reports | 4 | Oct 28, 2024 |
| 4 | Insider transactions | 1 | Oct 24, 2024 |
| 3 | Insider transactions | 1 | Oct 23, 2024 |
| 3 | Insider transactions | 1 | Oct 23, 2024 |
| 8-k | 8K-related | 15 | Oct 16, 2024 |
| 10-k | Annual reports | 89 | Oct 10, 2024 |